Budapest, Hungary

Laszlo Cibula


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Laszlo Cibula

Introduction

Laszlo Cibula, an accomplished inventor based in Budapest, Hungary, has made notable contributions to the field of organic chemistry. His innovative approach to the synthesis of optically active compounds highlights the importance of chirality in pharmaceutical applications.

Latest Patents

Cibula holds a significant patent for a process aimed at an enantioselective synthesis of optically active 14-oxo-E-homo-eburnane derivatives. This invention focuses on a novel method using optically active 6-alkoxycarbonylhexahydroindoloquinolizinium salts as starting materials. The synthesis not only preserves the optical activity from the original tryptophan ester but also allows for the eventual formation of a new center of chirality in the desired end product. The patent is crucial as the resulting compounds can be utilized in the synthesis of important pharmaceutical agents like (+)-vincamine and (+)-apovincaminic acid ethyl ester.

Career Highlights

Laszlo Cibula is affiliated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company where he has leveraged his expertise in medicinal chemistry. Through his career, he has been dedicated to advancing methodologies that enhance the efficiency and effectiveness of drug synthesis.

Collaborations

Throughout his professional journey, Cibula has collaborated with esteemed colleagues such as Csaba Szantay and Lajos Szabo. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and techniques that propel their collective research forward.

Conclusion

Laszlo Cibula's innovative contributions continue to resonate within the field of organic synthesis. His patent not only serves as a testament to his ingenuity but also contributes to the broader landscape of pharmaceutical development. As the industry evolves, his work remains a valuable asset to ongoing research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…